Phase II trial of RAD001 and bicalutamide for castration‐resistant prostate cancer
M Nakabayashi, L Werner, KD Courtney… - BJU …, 2012 - Wiley Online Library
Study Type–Therapy (cohort) Level of Evidence 2a What's known on the subject? and What
does the study add? Despite expanding treatment options for castration‐resistant prostate …
does the study add? Despite expanding treatment options for castration‐resistant prostate …
Phase II trial of RAD001 and bicalutamide for castration‐resistant prostate cancer
M Nakabayashi, L Werner, KD Courtney, G Buckle… - BJU International, 2012 - cir.nii.ac.jp
抄録< jats: sec>< jats: label/>< jats: p> Study Type–Therapy (cohort)</jats: p>< jats: p> Level
of Evidence 2a</jats: p>< jats: p>< jats: bold> What's known on the subject? and What does …
of Evidence 2a</jats: p>< jats: p>< jats: bold> What's known on the subject? and What does …
Phase II trial of RAD001 and bicalutamide for castration-resistant prostate cancer
M Nakabayashi, L Werner, KD Courtney… - BJU …, 2012 - pubmed.ncbi.nlm.nih.gov
Study Type--Therapy (cohort) Level of Evidence 2a. What's known on the subject? and What
does the study add? Despite expanding treatment options for castration-resistant prostate …
does the study add? Despite expanding treatment options for castration-resistant prostate …
Phase II trial of RAD001 and bicalutamide for castration-resistant prostate cancer
M Nakabayashi, L Werner… - BJU …, 2012 - utsouthwestern.elsevierpure.com
Abstract Study Type-Therapy (cohort) Level of Evidence 2a What's known on the subject?
and What does the study add? Despite expanding treatment options for castration-resistant …
and What does the study add? Despite expanding treatment options for castration-resistant …
Phase II trial of RAD001 and bicalutamide for castration-resistant prostate cancer.
M Nakabayashi, L Werner, KD Courtney… - BJU …, 2012 - europepmc.org
Objectives• To determine best overall response and duration of response of RAD001, a
selective inhibitor of mammalian target of rapamycin, in combination with bicalutamide in …
selective inhibitor of mammalian target of rapamycin, in combination with bicalutamide in …
Phase II trial of RAD001 and bicalutamide for castration‐resistant prostate cancer
M Nakabayashi, L Werner, KD Courtney, G Buckle… - BJU International, 2012 - infona.pl
Study Type–Therapy (cohort) Level of Evidence 2a What's known on the subject? and What
does the study add? Despite expanding treatment options for castration‐resistant prostate …
does the study add? Despite expanding treatment options for castration‐resistant prostate …
Phase II trial of RAD001 and bicalutamide for castration-resistant prostate cancer.
M Nakabayashi, L Werner, KD Courtney… - BJU …, 2012 - search.ebscohost.com
Abstract Study Type-Therapy (cohort) Level of Evidence 2a What's known on the subject?
and What does the study add? Despite expanding treatment options for castration-resistant …
and What does the study add? Despite expanding treatment options for castration-resistant …
[引用][C] Phase II trial of RAD001 and bicalutamide for castration―resistant prostate cancer
M NAKABAYASHI, L WERNER… - BJU international …, 2012 - pascal-francis.inist.fr
Phase II trial of RAD001 and bicalutamide for castration―resistant prostate cancer CNRS
Inist Pascal-Francis CNRS Pascal and Francis Bibliographic Databases Simple search …
Inist Pascal-Francis CNRS Pascal and Francis Bibliographic Databases Simple search …